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In the developed countries, great improvement had occurred in the 
management of childhood illnesses which made the congenital diseases a 
major cause of infant morbidity and mortality, neural tube defects(NTDs) 
being one of them. In the last two decades a great effort has been done on 
NTDs leading to reduction in their incidence. 
The objectives of this prospective hospital based study were to: 
1) determine the incidence of NTDs in Omdurman Maternity Hospital 2) 
describe the spectrum of NTDs, 3) detect any associated congenital 
anomalies 4) assess the role of the sociodemographic factors, and 5) study 
the short term outcome of NTDs. 
All babies born in Omdurman Maternity Hospital during the period from the 
1st  of February 2003 to the 31st  of January 2004 with clinically detectable 
NTDs were examined and for each case consecutive normal birth   was taken 
as a control. The surviving cases were followed up for the following three 
months. 
The incidence of NTDs was 3.48/1000, 47.6% of the cases were 
myelomeningocele, 36.5% were anencephaly, 14.2% encephalocele and one 
case was iniencephaly. Most of the cases were either stillborn or died in the 
early neonatal period. The male to female ratio was 1:5 and 20 % of the 
NTDs had other congenital anomalies . About 60% of the mothers were less 
<25 years of age and there was a significant association between NTDs and 
mother age (relative risk 2.3, p<O.0001). Most of the parents of babies with 
NTDs had poor educational background , 54.8% of mothers had a significant 
history of previous stillbirth delivery. Only 30% of mothers had antenatal 
care. No mothers from the case or control group  had used folic acid 
preconceptionally.  
It is concluded that the incidence of NTDs in Omdurman Maternity Hospital 
is the highest in Africa and this invites a nationwide registry for all 
congenital anomalies and improvement in the obstetric services including 
active promotion of folic acid supplementation programs. 
 ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ
ﻟﺠѧﺔ أﻣѧﺮاض اﻟﻄﻔﻮﻟѧﺔ ﻓѧﻲ اﻟѧﺪول اﻟﻤﺘﻘﺪﻣѧﺔ اﻷﻣѧﺮ اﻟѧﺬ ﻳﺠﻌѧﻞ ﻟﻘѧﺪ ﺣѧﺪث ﺗﻘѧﺪم آﺒﻴѧﺮ ﻓѧﻲ ﻣﻌﺎ
. اﻟﻌﻴﻮب اﻟﺨﻠﻘﻴﺔ ﻣﻦ أهﻢ أﺳﺒﺎب أﻣﺮاض ووﻓﻴѧﺎت اﻷﻃﻔѧﺎل وأﺣѧﺪهﺎ ﻋﻴѧﻮب اﻟﻘﻨѧﺎة اﻟﻌѧﺼﺒﻴﺔ 
ﺧѧﻼل اﻟﻌﻘѧﺪﻳﻦ اﻷﺧﻴѧﺮﻳﻦ ﺗѧﻢ ﻋﻤѧﻞ اﻟﻜﺜﻴѧﺮ ﻣѧﻦ اﻟﺠﻬѧﺪ ﻣﻤѧﺎ أدي إﻟѧﻰ إﺣﺘѧﻮاء وإﻧﻘѧﺎص ﻧѧﺴﺒﺔ 
  .ﺣﺪوث ﻣﺜﻞ هﺬﻩ اﻟﻌﻴﻮب
ﺔ ﻋﻴﻮب اﻟﻘﻨﺎة اﻟﻌﺼﺒﻴﺔ ﻓﻲ ﻣﺴﺘﺸﻔﻲ اﻟﻮﻻدة أﻣѧﺪرﻣﺎن ﺗﺤﺪﻳﺪ ﻧﺴﺒ . 1 :أهﺪاف هﺬﻩ اﻟﺪراﺳﺔ 
دراﺳѧﺔ دور . 4. اﻟﻜﺸﻒ ﻋﻦ وﺟﻮد ﻋﻴﻮب ﺧﻠﻘﻴѧﺔ أﺧѧﺮي . 3ﻣﻌﺮﻓﺔ ﻧﻮﻋﻴﺔ هﺬﻩ اﻟﻌﻴﻮب . 2
  .دراﺳﺔ ﻣﺤﺼﻠﺔ هﺬﻩ اﻟﻌﻴﻮب ﺑﻌﺪ اﻟﻤﺘﺎﺑﻌﺔ. 5. اﻟﻌﻮاﻣﻞ اﻻﺟﺘﻤﺎﻋﻴﺔ واﻟﺒﻴﺌﻴﺔ
 ﺑﺪاﻳѧﺔ ﻓﺒﺮاﻳѧﺮ ﺗﻢ إﺟﺮاء هﺬﻩ اﻟﺪراﺳﺔ ﻓﻲ ﻣﺴﺘﺸﻔﻲ اﻟﻮﻻدة أﻣﺪرﻣﺎن ﻓﻲ ﻣѧﺪة ﻋѧﺎم آﺎﻣѧﻞ ﻣﻨѧﺬ 
ﺗﻢ اﺳﺘﻘﺼﺎء آﻞ اﻻﻃﻔﺎل اﻟﺬﻳﻦ ﺗﻢ وﻻدﺗﻬѧﻢ ﺑﻌﻴѧﻮب اﻟﻘﻨѧﺎة . م4002م إﻟﻰ ﻧﻬﺎﻳﺔ ﻳﻨﺎﻳﺮ 3002
  . اﺷﻬﺮ3اﻟﻌﺼﺒﻴﺔ ﺧﻼل هﺬﻩ اﻟﻔﺘﺮة وﺗﻢ ﻣﺘﺎﺑﻌﺔ اﻷﺣﻴﺎء ﻣﻨﻬﻢ ﻟﻤﺪة 
ﺳѧﺘﻮن ﻓѧﻲ اﻟﻤﺎﺋѧﺔ ﻣﻨﻬѧﺎ آﺎﻧѧﺖ ﺣѧﺎﻻت .  ﻟﻜﻞ أﻟѧﻒ 84.3ﻧﺴﺒﺔ ﺣﺪوث ﻋﻴﻮب اﻟﻘﻨﺎة اﻟﻌﺼﺒﻴﺔ 
ﺧѧﺮوج آѧﻴﺲ ﻣѧﻦ اﻟѧﺮأس، وﺣﺎﻟѧﺔ واﺣѧﺪة اﻟﺘﺤѧﺎم % 01 ﺑѧﺪون رأس،% 83ﻓﺘѧﺎق اﻟﻈﻬѧﺮ، 
  .اﻟﺮأس ﻣﻊ اﻟﻈﻬﺮ
ﺛﻤѧﺎﻧﻮن ﻓѧﻲ اﻟﻤﺎﺋѧﺔ ﻣѧﻦ هѧﺬﻩ اﻟﺤѧﺎﻻت ﺗѧﻢ وﻻدﺗﻬѧﻢ ﺳѧﻘﻄًﺎ أو ﺗﻮﻓѧﻮا ﺧѧﻼل اﻟѧﺸﻬﺮ اﻷول ﻣѧﻦ 
ﻣﻦ اﻟﺤﺎﻻت ﺻﺎﺣﺒﺘﻬﺎ ﻋﻴﻮب ﺧﻠﻘﻴѧﺔ % 02 ، 1:5ﻧﺴﺒﺔ اﻟﺬآﻮر إﻟﻰ اﻹﻧﺎث آﺎﻧﺖ . اﻟﻮﻻدة 
ﻣѧѧﻦ اﻵﺑѧѧﺎء % 06 ﺳѧѧﻨﺔ ، 52ﻦ ﺳѧѧﺘﻮن ﻓѧѧﻲ اﻟﻤﺎﺋѧѧﺔ ﻣѧѧﻦ اﻷﻣﻬѧѧﺎت آѧѧﻦ أﺻѧѧﻐﺮ ﻣѧѧ. أﺧѧѧﺮي
 ﻣѧﻦ اﻷﻣﻬѧﺎت آѧﺎن ﻟѧﺪﻳﻬﻦ ﺗѧﺎرﻳﺦ وﻻدة 8.75واﻷﻣﻬѧﺎت آﺎﻧѧﺖ درﺟѧﺔ ﺗﻌﻠѧﻴﻤﻬﻢ ﻣﻨﺨﻔѧﻀﺔ، 
آѧѧﻞ اﻷﻣﻬѧѧﺎت ﻟѧѧﻢ . ﻓﻘѧѧﻂ ﻣѧѧﻦ اﻷﻣﻬѧѧﺎت آѧѧﻦ ﻳﺘѧѧﺎﺑﻌﻦ أﺛﻨѧѧﺎء اﻟﺤﻤѧѧﻞ % 03ﻃﻔѧѧﻞ ﻣﻴѧѧﺖ آﻤѧѧﺎ أن 
  .ﻳﺴﺘﻌﻤﻠﻦ ﺣﺎﻣﺾ اﻟﻔﻮﻟﻴﻚ ﻗﺒﻞ اﻟﺤﻤﻞ
ﻲ اﻟѧﻮﻻدة أﻣѧﺪرﻣﺎن ﺧﻠﺺ اﻟﺒﺤﺚ إﻟﻰ أن ﻧѧﺴﺒﺔ ﺣѧﺪوث ﻋﻴѧﻮب اﻟﻘﻨѧﺎة اﻟﻌѧﺼﺒﻴﺔ ﻓѧﻲ ﻣﺴﺘѧﺸﻔ 
هﻲ اﻷﻋﻠﻰ ﻓﻲ أﻓﺮﻳﻘﻴﺎ وهﺬا ﻳﺴﺘﻠﺰم ﻋﻤﻞ ﺗﺴﺠﻴﻞ ﻟﻜѧﻞ اﻟﻌﻴѧﻮب اﻟﺨﻠﻘﻴѧﺔ وﺗﺤѧﺴﻴﻦ اﻟﺨѧﺪﻣﺎت 
اﻟﺘѧﻰ ﺗﻘѧﺪم ﻟﻠﻨѧﺴﺎء ﻗﺒѧﻞ اﻟѧﻮﻻدة وﺗﻨﻈѧﻴﻢ ﺑѧﺮاﻣﺞ ﻟﻠﺘﻮﻋﻴѧﺔ ﺑﺄهﻤﻴѧﺔ أﺧѧﺬ ﺣѧﺎﻣﺾ اﻟﻔﻮﻟﻴѧﻚ ﻗﺒѧﻞ 
  . اﻟﺤﻤﻞ
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 1. NEURAL TUBE DEFECTS 
1.1. Definition: 
Neural tube defects (NTDS) are congenital structural abnormalities of: the 
brain, skull and spinal cord. They arise during the first 28 days of gestation 
when the neural tube is forming.  They can be isolated (commoner)or arise 
as part of a syndrome (syndromic).Syndromes known to contain NTDs 
include MeckelGruber, Robert, HARDES, the trisomies 13, 18, and Down 
syndrome. 
They are a major cause of stillbirth, neonatal and infant deaths or severe life 
long handicaps (1). 
1.2. Embryology of the neural tube: 
Figure A: simplifies the steps of neural tube formation in utero. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig A Steps of Neural tube formation. (Reproduced 
from Grays and Harley book of Anatomy 1927) 
 
 
The neural groove and folds are first seen during stage 8(about 18 days post 
ovulation)two days later, (stage 9) the three main divisions of the brain 
which are not cerebral vesicles can be distinguished. While the neural 
groove is still completely open, two days later, (stage 10) the neural folds 
begin to fuse near the junction between the brain and spinal cord, when the 
neural crest cells are arising mainly from the neural ectoderm. The cephalic 
neuro pore closes within a few hours during stage 11(about 24 days). The 
closure is bidirectional; it takes place from the dorsal and terminal lips and 
may occur in several areas simultaneously. The two lips however behave 
differently. The caudal neuropore takes 9 days to close during stage 
12(about 26 days) and the level of final closure is approximately at future 
somatic pair 31 which corresponds to future second sacral vertebra . At stage 
13 (4 weeks) the neural tube is normally completely closed (2). 
1.3. Classification: 
NTDs are classified as 
i. Open: when either the membranes or the neural tissue or both are exposed 
to the amniotic fluid. 
ii. Closed: when either of the above is covered with skin. NTDS are further 
subclassified as: 
 
1.3. a: CRANIAL DEFECTS 
i. Anencephaly:(Fig. B) 
This is the most severe and second commonest form. Here the fore- brain, 
meninges, vault of the skull, and the scalp fail to form.the condition is 
incompatible with life leading to stillbirth delivery or early neonatal death 
(3) 
ii. Exencephaly (craniorachiasis) (Fig.B) 
Here there is failure of scalp and skull formation with protrusion of 
abnormally formed brain. It is rare and incompatible with life (3). 
0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig B: Types of Neural tube defects. (Reproduced from 
Grays & Harley book of Anatomy 1927) 
iii. Encephalocele (Fig. B) 
This comprises 10% of NTDs .There is extrusion of brain tissue through a 
defect in the skull (3). 
iv. Iniencephaly:(Fig. B) 
There is a defect in the cervical, and upper thoracic vertebrae and the base of 
the skull with abnormally formed brain tissue and extreme retroflexion of 
the upper spine. It is rare and incompatible with life (3). 
1.3. b: THE SPINAL DEFECTS (SPINA BIFIDA) 
I. Meningocele (Fig.B) :is due to failure of fusion of the vertebral arches 
so the meninges are exposed to the amniotic fluid (3). 
II. Myelomeningocele(Fig. B): 
Failure of fusion of the vertebral arches with protrusion of both the 
meninges and the neural tissue to the amniotic fluid. The neural tissue is 
damaged by such exposure and accordingly the structures supplied by the 
damaged nerves will be nonfunctioning.e.g lesions of the lumbosacral area 
cause paraplegia + bowel and bladder dysfunction .Higher lesions affect 
more structures and thus cause more handicap. 
Open spinal defects are associated with ventriculmegaly or hydrocephalus. 
 
1.4: Burden of suffering: 
NTDs cause substantial morbidity and mortality .Anencephaly and the other 
cranial defects are almost always lethal. Spina bifida can range from mild 
(closed spina bifida) to severe form (open myelmeningocle). 
Aggressive surgical and medical cares are always required for the severe 
form. Special schooling and rehabilitation are needed for the patients with 
permanent disabilities. Based on 1988 cross — sectional data, the estimated 
life time cost of spin bifida is $25 8.000 per case. (4) 
 
1.5: Risk factors: 
a. Familial: 
Neural tube defects can run in families; parents with affected children have 
increased chance of having another one with the defect and the incidence 
increases with increasing family history (0.3% when no family history to 
43% when either both parents have NTD or there are two previous children 
with NTD (5). 
Genetically: many studies were done to disclose why some persons are more 
prone to be affected by NTDs than others and hence why do NTDs run in 
some families. These studies demonstrated that the condition is due to 
mutations in the enzyme (MTHFR) gene, the known mutation now is the 
677C     T mutation and only one copy is needed for the expression of this 
gene making the person vulnerable to NTD(5-7). 
There are additional folate-related genes that contribute to NTDs occurrence 
including mutant forms of folate receptors such as FRalpha. Genetic 
association between molecular variants of the FRalpha gene and NTDs have 
been documented suggesting that this gene may be a risk factor for human 
NTDs (5). These genetic studies may explain why certain ethnic a groups are 
more vulnerable to NTDs than the others. However, more than 90% of NTD 
cases occur with no previous family history (5-7). 
b. Diet: 
Folic acid deficiency is now known to be associated with high incidence of 
NTDs (7). 
c. Certain diseases: 
There are certain diseases that are known to be associated with NTDs in the 
off spring like insulin dependant diabetes mellitus(IDDM) and 
hypothyroidism. 
d. Drugs: 
Drugs such as anti convulsants e.g. valproic acid anti malarials 
e.g. Fansidar; these act as antifolates and antagonize the action of folate in 
intermediary metabolism (8). 
e. Maternal hyperthermia: during the first trimester is reported to cause 
NTDs although the mechanism is not known (8). 
1.7 Incidence: 
Globally 500.000 children are born each year with NTDs. 
The highest incidence reported was in a rural area in northern China where 
the incidence was 6/1000 before the supplementation of women in the child 
bearing age with folic acid when the incidence dropped to 2/1000 (9). In the 
USA the incidence now is 1/1000 after the nationwide fortification of diet 
with folic acid and NTDs are more prevalent among the Hispanic and non-
Hispanic whites compared of the Blacks, and predominantly in the younger 
age group of mothers (10). 
In Europe: the incidence was highest in Ireland among the Celtic 
population, it was 4/1000 (11). In Canada the incidence dropped from 
16.4/10.000 to 8.6/10.000 after fortification of diet with                          
folic acid (12). 
1.7.1. Incidence and prevalence in Africa: 
Malawi 2000: The incidence of spina bifida in one central hospital was 
0.47/1000(13). 
Tunisia 2000- 2001: The incidence of encephalocele is 0.25/1000 and the 
females are affected more than the males. It is associated with other 
malformations like : faciaI(2O%) skeletal (17%) and renal system (3%) (14). 
The incidence. of spina bifida was 1.05/1000 (15). 
 
 
Cape Town (South Africa 1994): 
The prevalence of NTDs was 1.74/1000; the highest rate was among the 
whites more than the blacks, and NTDs affected 
female babies more than males (16). 
Ghana: (1991-1992): the prevalence was 1.15/1000, anencephaly was 73% 
and spina bifida 27 %( 17). 
Congo: 1993: The incidence of anencephaly was 0.12/1000 and the 
suggested cause for the occurrence of spina bifida was the consumption of a 
type of potatoes infected with phytophotora infestation (18.). 
1.7.2: Neural tube defects and Sudan: 
No study has been done in Sudan focusing on NTDs. In the study done on 
hydrocephalus in Sudan by Ibrahim Abdelaziz in a 4 year period from 1971 
to 1974, out of 101 cases of hydrocephalus there Were 4 cases with 
meningocele (19). From the hospital records in Omdurman Maternity 
hospital, the number of spina bifida cases admitted to the neonatal care unit 
had increased during the last three years, no cases were admitted in the year 
2000, 13 cases were reported in 2001 and 33 cases in 2002. 
1.8. Screening and prenatal diagnosis: 
This is offered mostly to women at risk of having an NTD pregnancy. NTDs 
can be detected in utero by the following methods: 
i. Measurement of maternal serum alpha feto protein(MSAFP) 
ii. Ultra sound scanning. 
iii. Amniotic fluid acetyleholine esterase (AFAchE). 
iv. Amniotic fluid alpha feto protein (AFAP). 
The latter two are used primarily as confirmatory tests and are not 
regarded as part of the routine screening of women at risk  (20). 
1.8.1MSAFP: 
This is measured at 16-18 weeks of gestation It is a good predictor of NTDs. 
Depending on the cut off level used to define an elevated level (usually 2-2.5 
times the median value for gestational age reported as multiples of the 
median MoM), screening can detect between 56%-91% of affected fetuses 
(20). An elevated MSAFP occurs in 1-5% of pregnant women but for a 
number of reasons the likelihood of an NTD giving a positive screening 
result is small for the following reasons: 
First: above one third of positive results are not confirmed by a second 
MSAFP (i.e false positives) second : although the reported sensitivity of 
MSAFP when followed by appropriate diagnostic u/s. AFAP approaches 
.100 % MSAFP tests are not specific: there are other conditions that can 
cause high MSAFP they include: under estimated gestational age, other 
congenital anomalies like anterior abdominal wall defects, multiple gestation 
etc. These  false  positive  results  are  ruled out by u/s or (if u/s was not 
informative)  by amniocentesis (to measure AFAFP and AFAchE) (20). 
In comparison to the number of women who must be tested the number of 
NTDS detected by amniocentesis is small (0.06- 0.16%). That is because 
more than 90% of NTDs occur in women with no previous risk (20). 
1.8.2 Ultrasound scan: 
All cases of anencephaly can be detected by U/S alone as can many closed 
neural tube defects that escaped detection by MSAFP measurement current 
ultrasound techniques are less sensitive in detecting other NTDs like small 
meningoceles; so U/S scanning needs appropriate machine and expert 
training to avoid under or over diagnosis of NTDs. In centers where there is 
appropriate machines and expert trainee the specificity of U/S scanning 
reaches 100% (20). 
1.8.3 Benefits of screening: 
The benefits of prenatal screening are: 
a) to inform prospective parents of the likelihood of carrying an NTD 
pregnancy. Parents may be counseled about the consequences of the 
malformation and can make decisions about keeping it or preparing the 
optimal care for their future baby or choose to have elective abortion ;for 
example, the prenatal diagnosis of anencephaly can spare parents some of 
the trauma associated with delivering such malformation (20). 
b)Induced abortion is sought by the majority of women in the United 
Kingdom where screening by MSAFP and U/S are 
widespread. It is reported that there was 49-50% decline in the birth 
prevalence of anencephaly and 32-38% decline in spina bifida rates 
attributable to elective abortions (20). 
The effectiveness of reducing the prevalence of NTDs by screening and 
early detection is limited by the universal acceptance of screening and the 
cultural and religious backgrounds concerning acceptance of abortion (21). 
1.8.4: Potential risks of screening: 
The most important risks include ;l) the risk to the fetus from 
amniocentesis,2) the psychological effects on the parents of positive 
results,3) the complications of induced abortion. and 4) the risks of elective 
abortion. 
i.Risk to the fetus from The amniocentesis : 
This inc1ude: miscarriages, puncture to the fetus, bleeding, infection and 
possibly isoimmunisation .the procedure related rate of fetal loss with 
current technique is about 0.5-0.8% (22). 
ii.Psychological effect on the parents of a positive test:  
This is especially important because the large majority of positive 
screening tests in low risk mothers are false positives. There is statistical 
evidence that expectant parents with normal fetuses suffer a great deal of 
anxiety while awaiting confirmatory tests (22). 
 
iii. The potential complications of induced abortion:  
The maternal case fatality rate from legaly induced abortion is 
0.4/100.000 procedures. 
iv. The induced abortion of a normal fetus: 
This is a very serious consequence of false positive results, but appears 
to be very uncommon with current diagnostic techniques. Investigators 
have reported false positive results leading to elective abortion of 
normal fetuses to be less than 0.006 -0.007 %of women screened (22). 
1.9: Prevention: 
It is now well proven that folic acid deficiency is closely related to NTDs 
occurrence. A number of large population based studies associating maternal 
folate deficiency with NTDs serve as the scientific basis for prevention by 
folic acid(21-23). 
1.9.1 What is folic acid/.folate?: 
Folate is a member of the water soluble vitamin B complex; folic acid is the 
synthetic form of it. 
1.9.2:Foods rich in folates: 
Vegetables, cabbage, cauliflower, English spinach, green beans, grapefruits, 
orange, soya beans, lentils, haricot beans, eggs, peanuts, many apples and 
orange juices. Folate is an inclusive term for biologically active forms of 
pterylglutamic acid (23).  
1.9.3: Role of folates in intermediary metabolism: 
Naturally occurring folate include dihydro and tetra hydro folate and may 
have up to seven additional glutamic acid residues. Synthetic folic acid is an 
oxidized form with one glutamic acid residue; it must be oxidized to 
tetrahydrofolate to be biologically active. Dyhydrorofolate is an important 
co-factor for metabolic reactions modify organic molecules by adding or 
removing a single carbon (methyl) unit; these reactions are essential for 
DNA synthesis and cell division. These reactions are rate limited by the 
enzyme methylenetetrahydrofolate reductase (MTHFR) which catalyses the 
conversion of homocysteine to methionine. Homocysteine accumulates if 
conversion to methionine is slowed because of shortage of folates or 
inherited enzyme variants. A raised homocysteine suggest suboptimal 
nucleic acid and amino acids metabolism. It also has a direct atherosclerotic 
effects on the blood vessels and hence increasing the possibility of vascular 
diseases and stroke and may increase the risk of certain cancers and 
dementia (23, 24). 
1.9.4: Methods of prevention by folic acid: 
The recommendation now is to take folic acid precoceptionally i.e. before 
the woman try to get pregnant. In 1992 ,the United States Public Health 
Service (USPHS) recommended that all women in the child bearing age 
should consume 400 micrograms of folic acid on an ongoing basis to reduce 
the risk of having a pregnancy affected by NTDs This recommendation was 
preceded a year before by the recommendation of the Center of Disease 
Control and Prevention (CDC) for women at high risk (women who had an 
earlier pregnancy affected with NTD) to consume 4.000 micro gram of folic 
acid from the time they try to conceive through the first trimester of 
pregnancy to reduce the risk of having a NTD (25). 
Why should folic acid be taken preconceptionally?: 
Because the neural  tube  formation  occurs  in the first 28 days of gestation 
even before the woman recognizes  that  she  is it pregnant (26). 
1.9.5:Ways of achieving increased folic acid consumption: 
There are many ways do this: 
a. By increasing the consumption of foods rich in naturally occurring folates. 
b. By increasing the use of folic acid containing pills before conception. 
c.By fortification of a staple food stuff (e.g. flour, sugar. etc) with folic acid. 
 In 1998 the CDC in U.S.A mandated a nationwide fortification of enriched 
grain products with folk acid (the synthetic form of folates. 
The food and drug administration (FDA) chose to require a concentration of 
folic acid that increase women consumption by 100 microgram /day, the 
concentration required was 140 microgram of folic acid /100 gram of grain 
or 1.4 parts/1 .000.000 (27-30). 
Other countries that mandated fortification with folic acid include: Canada 
(1998) Chile and some other Countries In the Americas. Selected foods are 
also fortified in Hungary (31). 
1.9.6: How much is folic acid fortification effective: 
Folic acid proved to be effective in preventing NTDs. In a 1999 study, the 
CDC reported its results of a randomized control trial of folic cid use 
precoceptionally in a rural area in Northern China Where the incidence was 
6/1000, women took 400 microgram daily from the time of their premarital 
examination until the end of their first trimester of pregnancy , the incidence 
dropped to 1/1000. In the U.S.A: the incidence dropped by about 50 %( 3 1) 
1.9.7 Fortification in contrast to supplementation: 
Supplementation is effective but it depends on the women awareness of the 
importance of folic acid, their level of education and cultural influences. At 
sufficiently high serum/plasma folate concentrations (adequate) 
homocysteine concentrations are reduced and there is a linear increase in 
homocysteine concentrations as folate levels decline (32). 
1.9.8 Other beneficial effects of folic acid supplementation: 
Many studies have proved that folic acid prevents the occurrence of 
atherovascular disease like heart attacks and strokes, some cancers like 
cancer of the colon and pernicious anemia caused by folate deficiencies. 
Homocysteine has direct atherosclerotic changes to the blood vessels 
increasing the chance of strokes and heart attacks and since homocystiene is 
inversely related to folate, so increasing consumption of folic acid decreases 
the occurrence 
of these conditions. A large multi center European study published in 1997 
concluded that consumption of a simple multivitamin pill containing folic 
acid is associated with a strong protective effect- a statistically significant 
(62%) reduction in atherovascular disease (33). Folate deficiency causes 
mutations in DNA synthesis and so can play a role in colonic cancer hence 
folate supplementation reduces the risk of this cancer by 75 % (34). 
 
Justifications: 
• Neural tube defects cause significant morbidity and mortality in 
children. 
• Few studies have been done focusing on neural tube defects in 
Sudan. 
• Prevention of neural tube defects is cost effective while 
management of residual damage and handling of complications is 
costly and tasking. 
Objectives: 
The objectives of the study were to: 
1. Determine the incidence of NTDs in Omdurman Maternity Hospital. 
2. Describe the spectrum of NTDs. 
3. Detect any associated congenital anomalies. 
4. Assess the role of sociodernographic factors. 
5. Study the short term outcome of NTDs. 
2. MATERIALS AND METHODS 
2.1: Study design: 
The study was a prospective hospital based case-control study. 
2.2: Study area: 
The study was conducted in Omdurman Maternity Hospital; this is one of 
the biggest hospitals in the country and the first hospital specialized in 
obstetric care. The nucleus of the hospital as a midwifery school was 
founded in 1921 in Omdurman City which is considered to be the national 
capital of Sudan and is inhabited by about three million people of different 
ethnic groups and coming from all parts of the country. The hospital has a 
very high delivery rate between 15.000-18.000 delivery per year. It has also 
got a neonatal care unit which accepts about 100-120 neonate per month. 
The Obstetric Department consists of: an Emergency Department with the 
labour room accepting about 60-100 delivery per day, two theatres, referral 
clinics for antenatal care and follow up, ultrasound department as well as the 
well recognized midwifery school. 
2.3: Study duration: 
A one yea study: 1st February 2003- 31st January 2004 
2.4: Study population: 
All infants (live birth and still birth) born in Omdurman Maternity 
Hospital during the study period. 
2.5: Sample size: 
N=Z2 (p1 .ql+p2.q2)/d2 
N= (1.96)2 (0 .5x0. 5+0 .5x0 .5)/0 02=70 
N=sample size 
Z=statistical certainty 
P1=probability of success in case finding. 
 q1= probability of failure in case finding. 
p2= probability of success in control finding. 
q2=probability in failure in control finding. 
2.6: Inclusion criteria: 
2.6.1: Study group: 
Babies (livebirth & stillbirth) born in Omdurman Maternity Hospital with 
clinically detectable NTDs. 
2.6.2: Control group: The nearest subsequent baby delivered after the case 
was taken as a control. The number of the controls was double the cases. 
2.7: Exclusion criteria: 
Babies excluded from the study were: 
Babies born outside the hospital. 
Babies whose their parents refused to participate in the study. 
 
2.8: Research technique: 
2.8.1: Consent: 
An informed consent was obtained from the parents to include them in the 
study and to take photographs for the NTD cases. A written consent was 
obtained from the hospital administrator.  
2.8.2. Research tools: 
I. Questionnaire: A structured questionnaire sheet was used to collect data 
from the mother including informations about personal data, 
socioeconomic, medical and obstetric histories, the use of folic acid and 
mode of the delivery. 
II. Examination sheet: This is completed after examining the neoborn and 
included: 
a) gestational age assessment using Parkin method. 
b) general examination with search of any other congenital anomaly. 
c) anthropometric measure: using a non-stretchable plastic tape & 
measurements of head circumference and length were taken to the nearest 
centimeter. 
d) description for the NTD with its location. 
e) reporting of any neurological complication. 
 
 
III. Follow up sheet: 
The surviving cases were followed up for three months to report on the short 
term outcome (surgery, complications, death... etc) 
2.8.3: Research team: 
a. The author: the team leader who trained the other members of the research 
team in identifying the NTD cases, completing the questionnaires, 
examining the affected neoborns, and the controls. 
b. One house officer: His role was to stay in the labour room and report any 
NTD case. 
c. Two midwives from the labour room: Their job was to identify the NTD 
cases and to inform the doctor about them and complete the maternal 
data. (An Arabic questionnaire was used). 
d. One nurse from the Neonatal Care Unit: her role was to complete the 
questionnaire for NTD case admitted to the Unit. 
2.8.4 Verification of data: 
The author participated in completion of questionnaire and verified the data 
filled by the research team depending on the stay of the cases in the hospital. 
 
 
 
2.9: Data Analysis: 
• The data was entered in the computer using the soft ware, Fox Pro. 
• Simple descriptive statistics, frequency distributions and cross tabulation 
were done using Epinfo program (version 6). 
• Results were tested for significance using Odds ratio to calculate the 
relative risk (RR).X2 and Fisher Exact tests were used; a probability of < 
0.05 was considered to be significant. 
 
3. RESULTS 
Through out the study period from the first of February 2003 to the end of 
January 2004 in Omdurman Maternity hospital, l8378 deliveries were 
recorded. 
3.1: Incidence of Neural tube defects: 
Table 1. Describes the incidence of NTDs compared to other congenital 
anomalies at birth. The incidence of NTDs was 3.48/1000 .me incidence of 
other congenital anomalies at birth was 2.34/1000 and the incidence of all 
congenital anomalies including NTDs was 5.82/1000 thus :NTDs constituted 
59.4% of all congenital anomalies at birth. 
3.2: Spectruth and outcome of neural tube defects: 
As shown in Table2 and Figure 1: the most frequent NTD was the 
myelomenigocele (Fig. C), seen in 30 cases (47.6%), followed by the 
anencephaly (Fig. D), in 23 (36.5%) cases and then the encephalocele in 9 
(14.2%) 
 
  
 
Table 1.  Incidence of neural tube defects (NTDs) 
Total NTD's Feb 03 to Jan04 63 
Incidence of NTD's 
(recognized at birth per 1000 deliveries) 
3.48 
Incidence of other congenital abnormalities 
 (recognized at birth per 1000 deliveries) 
2.34 
Total incidence of congenital abnormalities  
(recognized at birth per 1000 deliveries)  
5.82 
NTD's as a % age of all congenital anomalies  
(recognized at birth) 
59.4% 
 
                                                                                                                                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig C: A Case with open myelomingocele 
 
  
 
Fig D: A case with anencephaly 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig E: A Case with Iniencephaly 
  
 
 
 
Table 2: Spectrum of NTDs 
NTD Total Still 
birth/NND 
Alive Taken 
home 
Anencephaly  23 23 0 0 
Encephalcoele 09 09 0 0 
Iniencephaly  01 01 0 0 
Myelomeningocele 30 19 10 01 
Total 63 52 10 1  
 
NTDs = Neural Tube Defects 
 
cases. A rare NTD (that is the iniencephaly (Fig. E)) was found in one case 
(1.5%). 
Regarding the outcome, most of the cases (n=52, 82.5%) were either 
stillborn or died within the neonatal period, only 10(15.9%) cases survived 
and one case was taken against medical advice. 
3.3: Gender distribution of Neural tube defects: 
Figure 2 shows the gender distribution of NTDs Females outnumbered 
males; there were 53 females (84%), 10 males(16%). 
3.4. Neural tube defects associated with other congenital anomalies: 
The study showed that 13(20%) of the NTDs had other congenital anomalies 
while 53 (80%)cases had no other congenital anomalies.these congenital 
anomalies were:cleft lip and palate (3cases), club foot (2 cases 
oexomphalos(1 case),genital prolapse (1case),accessory nipple with 
undecsended testes (1case,enophalmos with club foot (1 case),poly dactyly 
with palpable kidney and deficient abdominal wall (1 case). 
 
  
 
 
  
 
 
Table 3: Cases and other congenital anomalies. (n63) 
 No % 
Cases with other congenital anomalies 13 20 
Cases with out other congental anomalies  50 80 
Total  63 100 
 
3.5. Maternal age: 
It is shown in Table. 4 and Figure 3 that most of the mothers (n=55, 55.6%) 
of babies with NTDs were in the younger age group: from 15 -24 years, and 
the relative risk was 2.3 i.e. the mother had 2.3 times the chance of having 
an NTD baby when she is below 25 years of age which is strong1y 
statistically significant (p< O 0001) This is in contrast to the control group 
where most of the mothers (n92, 74.8%) were more than 25 years of age. 
3.6. Maternal and Paternal Educations: 
Table 5 and Figures 4 and 5: shows that most of the mothers had poor 
educational background i.e. 48% had basic education and 27.4% were 
illiterate. This applies also for the fathers. In contrast most of the parents in 
the controls had higher secondary school education (32.3%) and the illiterate 
werel6.1% and basic (28.2%) groups and the percentage of university 
educated is recognizably higher i.e. 23.4%. 
3.7. Previous history of stillbirth: 
It is shown in Table 6 and Figure 6 that there was a strong association 
between having a NTD baby and previous stillbirth delivery i.e. 54.8% in the 
cases contrasting to 12.9% in the control group. The relative risk was 
3.3.and is highly significant (p<O.0001). 
  
 
Table 4: Maternal Age for cases (n=63) and for controls (n=125) 
Age group  Cases (%) Control (%) 
< 5yrs  0 0 
15 -24 yrs  55.6 25.2 
25 – 34 yrs 30.2 61.8 
35 yrs+ 14.3 13.0 
Maternal age under vs. over 25 yrs P<0.0001 
Relative risk 2.3(95% CI1.5-3.4) 
  
 
  
Table 5: Maternal education for cases (n=63) and for controls (n=125) 
Education level   Cases (%) Control (%) 
Illiterate  27.4 16.1 
Basic  46.8 28.2 
Secondary  19.4 32.3 
University  06.3 23.4 
P<0.0012 (chi-square test) 
Relative risk of NTD with less than secondary education. 
2.42 (95% CI1.48-3.95) 
  
 
 
  
 
 
 
 
  
 
 
 
 
Table 6: Previous history stillbirths for cases (n=63) and for controls 
(n=125) 
Previous stillbirths    Cases (%) Control (%) 
Yes  54.8 12.9 
No  45.2 87.1 
P<0.0001 (Fisher's exact test) 
Relative risk  3.30 (95% CI 2.26-4.83) 
 
3.8. Prenatal and Perinatal Periods: 
3.8.1: Antenatal care (defined as 2 or more visits): 
Figure 7 shows that fewer antenatal visits were made by of NTDs; only 19 
(30%) of mothers while most (70%) of the controls had antenatal care. 
3.8.2: Maternal previous medical illness: 
Only one (1 .5%) mother from the case group and 4(3%) mothers from the 
case group had previous medical problem (p=0. 1 (ns). 
3.8.3: Folic acid use before pregnancy: 
Table 7 shows that no mothers either from the cases or control group had 
used folic acid precoceptionally. 
3.8.4: Mode of delivery: 
In Figure 8 : it is shown that the most common mode of delivery in both the 
cases and control group was vaginal . (77.8%and 76% respectively), Lower 
segment cesarean sections (LSCS) were done in 22.2% among case mothers 
and in 23.4%in control mothers; 13 out of 14 NTDS delivered by LSCS 
were stillborn or died neonatally and 7 out of 14 had major cranial defects. 
 
  
 
Table 7: Folic acid use before pregnancy for cases (n=63) and 
for controls (n=125) 
 Cases (%) Control (%) 
F.A before pregnancy  0 0 
No F.A before pregnancy  63 125 
 
F.A= Folic acid. 

3.9: Family history of NTDS: 
No family history of NTDs was found in the case group (0%) and the 
corresponding figure was 0.8% in the control group (p=0.l (ns)) (see Table 
8). 
3.10: Consanguinity: 
In figure 9 it is shown that there was no significant difference between cases 
and controls (23froni the cases, 40 from the controls (p=O. 167) as regard to 
consanguinity. 
3.11: Previous child with neural tube defects or other congenital 
anomalies: 
No mother from either the case group (n=63) or the control group(n= 125) 
had a previous child with NTD or other congenital anomalies 
3.12:.Major consumption of Goats milk: 
Table 9 shows no significant difference in goat milk consumption by the 
case mothers or the control mothers (5, 4 respectively) :Antifolate drugs 
(e.g. Phenytion, Fansidar) use during pregnancy: was no case mothers who 
used antifolate drugs during pregnancy one control mother used them .(p=1). 
 
 
  
 
 
 
Table 8: Family history of neural tube defects  for cases (n=63) and for 
controls (n=125) 
FH.NTDS Cases (%) Control (%) 
Yes  0 1 
No  63 124 
Total  63 125 
 
FH.NTDS=  Family history of neural tube defects. 
 
  
 
 
 
 
 
Table 9: Goat milk consumption  for cases (n=63) and for controls 
(n=125) 
 Cases (%) Control (%) 
Goat milk  0 4 
No goat milk  63 121 
Total  63 125 
3.14. Tribes and ethnic group: 
Table 10 shows that most of the cases (40) and the controls (80) were 
coming from tribes originating in the west of the country i.e. no significant 
difference between both groups (p=O. 165) 
  
 
 
 
Table 10: Tribes and origins for cases (n=63) and for controls 
(n=125) 
Tribe from  Cases (%) Control (%) 
NORTH 13 (20.7 18 (14.4) 
SOURTH  02 (03.1) 10 (08.00) 
EAST  00 (0.0) 03(02. 3) 
WEST  40 (63.5) 80 (64.0) 
CENTER  08 (12.7) 14 (11.2) 
TOTAL  63 (100.0) 125 (100.0) 
 
P  = 0.147 (ns) 
4.1 DISCUSSION 
The study has been conducted prospectively in a hospital based setting that 
is Omdurman Maternity Hospital; thus it may not reflect the actual condition 
in the community especially that a huge number of deliveries occur at home. 
The incidence of NTDs during the study period from the first of February 
2003 to the end of January 2004 was 3.48/1000.This is the highest incidence 
in Africa compared to that in Malawi 0.47/1000, Tunis (1.05/1000), South 
Africa (1.74/1000), Congo (0.12/1000) and Ghana (1.15/1000). It is almost 
approaching the highest incidence reported in Europe that occurred in 
Ireland (4/1000) and it is higher than the incidence in U.S.A (l/1000) (14-
18,20,21 ,29). 
Looking at the spectrum of NTDs , o the study obviously reflected the 
severe end of the spectrum .This is recognized from the high anencephaly 
rate of 36.5% compared to 47.6% of spina bifida and adding to the severity 
is that most of the cases (80%) were either stillborn or died within the 
neonatal period. This is compatible to the findings in one study done in 
Malawi where most of the spina bifida cases ended lethally (14). 
One of the very rare forms of NTDs appeared in this study ,that is the 
iniencephaly (Figure D) which was reported in only one study done in 
Northern China in 1995 where the number of the rare forms of NTDs was 
high(24 ).  
The females outnumbered the males in this study (50 females: l0 males) with 
the male to female ratio of 1:5 .this is in agreement with most of the reports 
in the literature .In a study from Malawi, the male to female ratio was found 
to be 1:4, in another study in Cape Town the ratio was 0.89for spina bifida 
and 0.67 for anencephaly( 14-16). 
Interestingly 20% of NTDS had other congenital anomalies. This high 
occurrence of associated congenital anomalies means that the syndromic 
type of NTDS which is elsewhere considered to be rare is rather common in 
our community, and this stimulates more concern about genetic factors in 
the causation of NTDs in Sudan , inspite of the fact that no single mother 
from either the case group or the control group had family history of NTDs 
or other congenital anomalies. The association with other congenital 
anomalies was reported in the study done in Tunis by Soumaya SG et al.( 
15),however other operating environmental factors cannot be ruled out. 
Another interesting point which could be considered in the causation of 
NTDs is the consanguinity especially there is much concern about the 
genetics of NTDs .A recent study from Ireland found the mutation encoding 
for the variant gene of the enzyme MTHFR and it also found that it causes 
10 % of NTDs. (25). Sudan is known for the tradition of intermarriages in 
families but in this study no significant difference between cases and 
controls as regard to consanguinity. 
The maternal age and the level of education of both parents were taken as 
indicators for the socioeconomic status I t is assumed that if the mother is 
young and the level of to education is low, the socioeconomic status will be 
poor . As it is described in this study that most of the mothers were below 25 
years of age with a relative risk of 2.3 i.e. there was a strong association 
between the younger age, NTDs, and both parents having poor educational 
background. This relationship was proved by Myer who compared the 
prevalence of NTDs in North Carolina (USA) from 1995 -2001 and found 
that when the maternal level of education and their socioeconomic status 
improved, the prevalence of NTDs decreased (29). 
In this study there was a significant association between previous stillbirth 
delivery and NTDs this may throw more light on the severity of NTDs and 
put more questions about the cause of NTDs sin our community. 
The antenatal care was defined as 2 or more follow up visits during 
pregnancy. This study showed fewer mothers of cases had done antenatal 
care and accordingly they are more likely not to have done any ultra sound 
scans for the NTDs to be diagnosed. This might have led to the high 
incidence of NTDs if it is accepted that termination of pregnancy can reduce 
the incidence as in some community like the U.K and U.S.A where if the 
screening tests (including U/S) revealed NTDs the pregnancy is immediately 
terminated. ( 30 ). Moreover absent antenatal care deprives the mother from 
being given the information about the antifolate agents that should not be 
taken during pregnancy although no mother from the case group claimed 
taking these drugs .Also during the antenatal visits any maternal illness that 
can be associated with NTDs such as Diabetes or hypertension can be 
controlled. Yet in this study no significant number in the case mothers had 
any medical problem during pregnancy. 
A major intake of goats milk by the mother was postulated as a possible 
cause of folate deficiency as it is low in folate, but in this study no 
significant difference between cases or controls was found. 
It is well proven by many studies all around the world that Folic acid use 
preconcepionally (either by taking a diet high in folate or by 
supplementation before pregnancy or by fortification of diet) can reduce the 
incidence of NTDs besides improving the general health of the population. 
This had lead the Food and Drug Administration in USA (FDA) in 1998 to 
mandate a national fortification of flour with folic acid to reduce the 
incidence of NTDs and studies done afterwards proved that folic acid works 
in doing this. For example, the study done in a high prevalent area in 
Northern China where the incidence was 6/1000 and after folic acid 
supplementation the incidence was reduced to 2/1000. In this study no 
mother from the case or control group had any preconceptional folic acid 
supplementation and as they are of low socioeconomic status they were 
more likely to have a diet deficient in folic acid. 
The study showed that most of the mothers (cases and controls)were 
delivered by the vaginal route but still there was 14 NTD case (22%) 
delivered by lower segment cesarean section (LSCS ). This seems unfair on 
the mother who is going to have an NTD baby to be subjected to the hazards 
and complications of the operation and this could be avoided by doing 
ultrasound scans at least just once during pregnancy. However this remains a 
controversial issue. 
There is no mention in the literature that NTDs are concentrated in a certain 
ethnic population. The highest incidence of NTDs in Europe (4/1000) was in 
Ireland in a group of the population known to have Celtic origin but this 
high incidence was not due to genetic predisposition but because this group 
were known to eat a diet deficient in Folic acid. Most of the NTDs in this 
study came from tribes that have the west of Sudan as an original home but 
this was not significant since most of the controls were having the same 
pattern and this could be explained by that following environmental and 
political issues, Omdurman city became highly inhabited by people coming 
from western Sudan. This issue of genetic predisposition remains to be 
answered by further research. 
4.2. CONCLUSIONS 
•   The incidence of neural tube defects in Omdurman Maternity hospital 
during the year 2003-2004 was 3.48/1000. 
• NTDs constituted about 59% of all congenital anomalies at birth. 
• The male to female ratio was 1:5. 
• The lesions of NTDs were severe with high stillbirth/ NND rate. 
• NTDs accounted for 3.25/1000 live and stillbirths. 
• The high association with other congenital anomalies leads to the 
consideration of genetic factors in the causation of NTDs in Sudan. 
• Young maternal age, low educational level and previous history of 
stillbirth are strongly associated with NTD baby delivery. 
• Antenatal care was poor in NTDs mothers. 
• Most NTDs were not diagnosed before delivery. 
• Failure of antenatal diagnosis possibly leads to inappropriate LSCS. 
• There is still lack of evidence regarding the benefit of preconceptional 
use of folic acid in this study since none of the mothers of the cases or 
controls used this vitamin. 
 
4.3. RECOMMANDATIONS 
• The high incidence of NTDs in Omdurman Maternity Hospital 
constitutes a major health problem. This invites a nationwide registry 
for all congenital anomalies. 
• Improvement in antenatal care services is needed to assist in the early 
discovery of NTDs and accordingly to anticipate plans for the 
problem since termination of pregnancy is not acceptable in our 
community. 
• It is known that prevention is better than cure. Since folic acid is 
proved to reduce more than 70% of NTDs if used preconceptionally it 
is recommended for the health and medical authorities to increase the 
public awareness about folic acid and its beneficial effects on the 
public health as general and on reducing a grave congenital anomaly 
like NTDs; and to promote a nationwide programs to supplement folic 
acid to all women in the child bearing age .In a country like Sudan, 
this could only be achieved by legislation leading to fortification of a 
staple diet like bread, salt or Sugar by folic acid. 
• Further studies are needed to ascertain the incidence in the whole 
country and to disclose more informations about the cause of NTDs in 
Sudan. 
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